Literature DB >> 15130303

[Comparative study of clinical characteristics and prognosis of clinically diagnosed SARS patients with positive and negative serum SARS coronavirus-specific antibodies test].

Qing Tian1, You-ning Liu, Li-Xin Xie, Bao-xing Fan, Hong-min Xu, Wei-jun Chen.   

Abstract

OBJECTIVE: To investigate clinical characteristics and long-term effects of SARS.
METHODS: Clinical characteristics of 197 SARS patients in Xiao Tang-shan hospital were analyzed retrospectively, and prognosis of them were analyzed prospectively.
RESULTS: Among the 197 patients, 153 patients (77.7%) have positive results of serum SARS coronavirus-specific antibodies test, and 44 patients (22.3%) have negative results. The average age of SARS and non-SARS patients were (40 +/- 12) and (31 +/- 12) years, male/female ratio were 1.0:1.6 and 2.1:1.0, average body temperature were (38.5 degrees C +/- 0.3 degrees C) and (38.1 degrees C +/- 0.4 degrees C), median of fever length were 7.0 d (0.4 approximately 50 d) and 2.3 d (0.3 approximately 37 d) respectively. The occurrence of dyspnea, malaise and gastrointestinal symptom were more often in SARS patient than in non-SARS patients. Some patients have residual symptoms (such as cough, fatigue, dyspnea, abnormality of liver function, hyperglycemia and hyperglyceridemia), and only few patients have lung fibrosis.
CONCLUSION: Some patients with other respiratory diseases were misdiagnosed as SARS. There were several obvious differences of clinical characteristics between SARS patient and non-SARS patients. Prognosis of most patients were preciously well, and few still had abnormality of lung function. Residual symptoms of SARS and side effects of drugs used to treat SARS should be discriminated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15130303

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  3 in total

1.  Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience.

Authors:  Rong-Chang Chen; Xiao-Ping Tang; Shou-Yong Tan; Bi-Ling Liang; Zhuo-Yue Wan; Ji-Qian Fang; Nanshan Zhong
Journal:  Chest       Date:  2006-06       Impact factor: 9.410

2.  1-year pulmonary function and health status in survivors of severe acute respiratory syndrome.

Authors:  Kian-Chung Ong; Alan Wei-Keong Ng; Lawrence Soon-U Lee; Gregory Kaw; Seow-Khee Kwek; Melvin Khee-Shing Leow; Arul Earnest
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

3.  Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms.

Authors:  Melissa M Coughlin; John Babcook; Bellur S Prabhakar
Journal:  Virology       Date:  2009-09-12       Impact factor: 3.616

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.